Moreover, RasGRP3 mutation led to the promotion of cell proliferation, migration, and invasion, whereas NIS and TSHR expression and RAI uptake declined through AKT activation in thyroid cancer cells. This evidence concerns the gene AKT1 and thyroid gland carcinoma.